Since<unk>  resembles somatostatin in physiological activities, it can: * inhibit secretion of many hormones, such as gastrin, cholecystokinin, glucagon, growth hormone, insulin, secretin, pancreatic polypeptide, TSH, and vasoactive intestinal peptide, * reduce secretion of fluids by the intestine and pancreas, * reduce gastrointestinal motility and inhibit contraction of the gallbladder, * inhibit the action of certain hormones from the anterior pituitary, * cause vasoconstriction in the blood vessels, and * reduce portal vessel pressures in bleeding varices. It has also been shown to produce analgesic effects, most probably acting as a partial agonist at the mu opioid receptor. Pharmacokinetics<unk>  is absorbed quickly and completely after subcutaneous application. Maximal plasma concentration is reached after 30 minutes. The elimination half-life is 100 minutes (1.7 hours) on average when applied subcutaneously; after intravenous injection, the substance is eliminated in two phases with half-lives of 10 and 90 minutes, respectively.
Octreotide
Edotreotide
Lanreotide
Fertirelin
Metoclopramide
Tenatoprazole
Leuprorelin
Rabeprazole